Agenus and Zydus sign agreements for botensilimab and balstilimab

finance.yahoo.com/news/agenus-zydus-sign-agreements-botensilimab-113318320.html

In This Article:
Agenus has signed $141m partnership agreements with Zydus Lifesciences and its subsidiaries to enhance clinical developments and advance manufacturing globally while expanding patient access to botensilimab and balstilimab (BOT/BAL).
The agreement includes an exchange of…

This story appeared on finance.yahoo.com, 2025-06-04 11:33:18.
The Entire Business World on a Single Page. Free to Use →